Astraea

YC company profile

AI Operating System for Clinical Development

Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.

• YC batch: Spring 2026
• Founded: 2026
• Team size: 6
• Location: San Francisco
• Country: US
• Status: Active
• Industry: B2B
• Stage: Early
• YC partner: David Lieb

Founders

Joshua Wang — Founder/CEO

Stanford dropout previously studying CS and Math. Top 250 united states (USAMO) Qualifier, USACO Platinum, first intern at Salient (W23) developing enterprise systems.

LinkedIn · X

Sanmay Sarada — Founder/CTO

prev Data Engineer @ Baylor College of Medicine | 4 Publications in Fetal Medicine | CS and Bio at Stanford

LinkedIn

Source: Y Combinator · Retrieved 2026-11-02. Company information is self-reported on YC.